No Data
Shanghai Kehua Bio-EngineeringLtd (SZSE:002022 Shareholders Incur Further Losses as Stock Declines 11% This Week, Taking Three-year Losses to 55%
Kehua Tech Recognized in BNEF's Latest Bankability Survey
Kehua Ranked No.4 in the Global Modular UPS Market Share for Two Consecutive Years
Shanghai Kehua Bio-Engineering, Subsidiaries to Invest 68 Million Yuan for New Unit
Shanghai Kehua Bio-engineering (002022.SZ) plans to establish a subsidiary to undertake the Shaanxi Province High-Performance Diagnostic Medical Instruments Innovation Center project.
Shanghai Kehua Bio-engineering (002022.SZ) has announced the undertaking of the Shaanxi Province High-Performance Diagnostic Medical Instruments Innovation Center project...
shanghai kehua bio-engineering (002022.SZ): not involved in chip R&D business
Shanghai Kehua Bio-engineering (002022.SZ) stated on the investor interaction platform on November 28 that the company's main business is the research and development, production, and sales of in vitro diagnostic reagents and medical testing instruments. The company is not involved in chip business.
Investors Don't See Light At End Of Shanghai Kehua Bio-Engineering Co.,Ltd's (SZSE:002022) Tunnel And Push Stock Down 26%
No Data
